-
Value proposition
Decoding immune dysfunction at scale
Graph is a precision immunology techbio that leverages perturbation modeling from primary patient cell samples combined with multi-omics data to deliver transformative targeted therapies and biomarkers for immune-driven diseases. Graph believes that due to an incomplete understanding of complex immune-mediated diseases, millions of patients are left without adequate treatment options - and AI trained with complex disease data can solve this.
-
GraphTx
Graph Therapeutics - precision immunology
https://www.graphtx.com/
| Catalyst | Type | Tweets | Articles | |
|---|---|---|---|---|
daphni
Startup accelerator & VC, Venture Capital and Private Equity Principals (Auto) |
daphni
Startup accelerator & VC, Venture Capital and Private Equity Principals (Auto) |
Other
30 Jun 2026 |
|
|
Future4care
Startup accelerator & VC, Technology, Information and Internet (Auto) |
Future4care
Startup accelerator & VC, Technology, Information and Internet (Auto) |
Other
30 Apr 2026 |
|
|
AbbVie
Pharmaceutical, Pharmaceutical Manufacturing (Auto) |
AbbVie
Pharmaceutical, Pharmaceutical Manufacturing (Auto) |
Other
31 Oct 2025 |
|
|